Thank you for your interest in ZARS Pharma, Inc.  ZARS was acquired by Nuvo Research Inc. on May 12, 2011.  Nuvo is a specialty pharmaceutical company dedicated to building a portfolio of products primarily for the treatment of pain and the development of its immune modulating drug candidate WF10.

To read about the acquisition, click on the News Releases below.

News Releases

May 13, 2011

Nuvo Announces Completion of ZARS Pharma Acquisition

April 18, 2011

Nuvo Announces Agreement to Acquire ZARS Pharma

To view the Nuvo Research Inc. website visit - www.nuvoresearch.com